115 related articles for article (PubMed ID: 38554326)
21. Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer.
Philp L; Tannenbaum S; Haber H; Saini A; Laurent JS; James K; Feltmate CM; Russo AL; Growdon WB
Gynecol Oncol; 2021 Feb; 160(2):389-395. PubMed ID: 33358198
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of recurrence in early-stage endometrial carcinoma after delays in adjuvant radiation treatment.
Zhu S; Khalil R; Altairy O; Burmeister C; Dimitrova I; Elshaikh M
Int J Gynecol Cancer; 2021 Jan; 31(1):73-77. PubMed ID: 33087415
[TBL] [Abstract][Full Text] [Related]
23. Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer: Long-term outcomes of a randomised trial.
Reijntjes B; van Suijlichem M; Woolderink JM; Bongers MY; Reesink-Peters N; Paulsen L; van der Hurk PJ; Kraayenbrink AA; Apperloo MJA; Slangen B; Schukken T; Tummers FHMP; van Kesteren PJM; Huirne JAF; Boskamp D; Lunter G; de Bock GH; Mourits MJE
Gynecol Oncol; 2022 Feb; 164(2):265-270. PubMed ID: 34955237
[TBL] [Abstract][Full Text] [Related]
24. Lymph-vascular Space Involvement and/or p53 Overexpression Correlated With the Clinical Outcome of Early-stage Endometrial Cancer Patients Treated With Adjuvant Vaginal Brachytherapy.
Laliscia C; Gadducci A; Coccia N; Mattioni R; Fuentes T; Caretto M; Pistolesi S; Puccini P; Perrone F; Morganti R; Paiar F
Anticancer Res; 2023 Jan; 43(1):149-156. PubMed ID: 36585177
[TBL] [Abstract][Full Text] [Related]
25. Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer.
Han KH; Park NH; Kim HS; Chung HH; Kim JW; Song YS
Gynecol Oncol; 2014 Aug; 134(2):293-6. PubMed ID: 24854062
[TBL] [Abstract][Full Text] [Related]
26. Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy.
Kumar VJ; Nin CY; Kuei LY; Tan KH; Yeo R; Lam PY
Int J Gynecol Cancer; 2010 May; 20(4):564-9. PubMed ID: 20686374
[TBL] [Abstract][Full Text] [Related]
27. Pattern of recurrence in patients with endometrial cancer: A retrospective study.
Vizza E; Cutillo G; Bruno V; Sperduti I; Mancini E; Baiocco E; Chiofalo B; Cicchillitti L; Certelli C; Zampa A; Piccione E; Corrado G
Eur J Surg Oncol; 2020 Sep; 46(9):1697-1702. PubMed ID: 32204935
[TBL] [Abstract][Full Text] [Related]
28. The impact of tumor grade on survival end points and patterns of recurrence of 949 patients with early-stage endometrioid carcinoma: a single institution study.
Gayar OH; Patel S; Schultz D; Mahan M; Rasool N; Elshaikh MA
Int J Gynecol Cancer; 2014 Jan; 24(1):97-101. PubMed ID: 24264358
[TBL] [Abstract][Full Text] [Related]
29. Features of recurrence of endometrioid type endometrial cancer of I stage.
Movchan OM; Svintsitskiy VS; Tsip NP; Nespryadko SV; Bublіieva OI; Iurchenko NP
Exp Oncol; 2021 Dec; 43(4):365-369. PubMed ID: 34967538
[TBL] [Abstract][Full Text] [Related]
30. Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study.
Fu HC; Chen JR; Chen MY; Hsu KF; Cheng WF; Chiang AJ; Ke YM; Chen YC; Chang YY; Huang CY; Kang CY; Kan YY; Hsiao SM; Yen MS
J Gynecol Oncol; 2018 Sep; 29(5):e76. PubMed ID: 30022636
[TBL] [Abstract][Full Text] [Related]
31. A Proposal for a Classification for Recurrent Endometrial Cancer: Analysis of a French Multicenter Database From the FRANCOGYN Study Group.
Bricou A; Bendifallah S; Daix-Moreux M; Ouldamer L; Lavoue V; Benbara A; Huchon C; Canlorbe G; Raimond E; Coutant C; Graesslin O; Collinet P; Carcopino X; Touboul C; Daraï E; Carbillon L; Ballester M;
Int J Gynecol Cancer; 2018 Sep; 28(7):1278-1284. PubMed ID: 29994907
[TBL] [Abstract][Full Text] [Related]
32. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathological features and prognosis of patients in endometrial cancer with bone metastases].
Jiang F; Ren T; Cheng NH; Cao DY; Yang JX; Wu M; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2019 Jul; 54(7):452-457. PubMed ID: 31365957
[No Abstract] [Full Text] [Related]
34. Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma.
Panggid K; Cheewakriangkrai C; Khunamornpong S; Siriaunkgul S
J Obstet Gynaecol Res; 2010 Oct; 36(5):1044-8. PubMed ID: 21058438
[TBL] [Abstract][Full Text] [Related]
35. Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging.
Menderes G; Azodi M; Clark L; Xu X; Lu L; Ratner E; Schwartz PE; Rutherford TJ; Santin AD; Silasi DA
Int J Gynecol Cancer; 2014 Jul; 24(6):1118-25. PubMed ID: 24927247
[TBL] [Abstract][Full Text] [Related]
36. Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer.
Sapienza LG; Ning MS; de la Pena R; McNew LK; Jhingran A; Georgeon L; Rasool N; Gomes MJL; Abu-Isa E; Baiocchi G
Int J Gynecol Cancer; 2020 Oct; 30(10):1535-1541. PubMed ID: 32376738
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer.
Sears JD; Greven KM; Hoen HM; Randall ME
Cancer; 1994 Aug; 74(4):1303-8. PubMed ID: 8055452
[TBL] [Abstract][Full Text] [Related]
38. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
39. Use of Aggressive Surveillance for Locoregional Endometrial Cancer After Local Therapy.
Yalamanchi P; Shabason JE; Zhang X; Ko EM; Lin LL
Int J Gynecol Cancer; 2018 Sep; 28(7):1264-1270. PubMed ID: 30036223
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival.
Ly D; Rowley BD; Dodson MK; Soisson PA; Jolles CJ; Gaffney DK; Sause WT
Gynecol Oncol; 2014 May; 133(2):250-5. PubMed ID: 24589416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
